Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 42.90% is in line with its 5-year average of 40.39%, near the low end of its 5-year range (38.53%–54.30%).
1.01% above its 12-month average of 42.47%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 41.17%.
GROSS MARGIN
42.90%
GROSS MARGIN AVG TTM
42.47%
GROSS MARGIN AVG 3Y
40.72%
GROSS MARGIN AVG 5Y
40.39%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.01%
CURRENT VS 3Y AVG
+5.34%
CURRENT VS 5Y AVG
+6.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-27.28%
vs the sector median at left
GE HealthCare Technologies Inc.
Market Cap
$30.10B
Gross Margin
42.90%
TTM Avg
42.47%
3Y Avg
40.72%
5Y Avg
40.39%
Market Cap
$30.55B
Gross Margin
59.30%
TTM Avg
57.84%
3Y Avg
57.54%
5Y Avg
57.23%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (GEHC) | $30.10B | 42.90% | 42.47% | 40.72% | 40.39% |
| Zoetis Inc. (ZTS)vs › | $29.79B | 70.87% | 69.79% | 68.91% | 68.46% |
| Centene Corp. (CNC)vs › | $30.53B | 16.13% | 11.28% | 11.33% | 11.71% |
| Mettler-Toledo International Inc. (MTD)vs › | $30.55B | 59.30% | 57.84% | 57.54% | 57.23% |
| Medline Inc. (MDLN)vs › | $29.34B | 25.02% | 25.55% | 23.71% | 23.71% |
| Alcon Inc. (ALC)vs › | $31.44B | 56.45% | 55.42% | 55.20% | 53.33% |
| ResMed Inc. (RMD)vs › | $32.20B | 61.16% | 60.26% | 58.24% | 57.85% |
| DexCom, Inc. (DXCM)vs › | $32.69B | 62.47% | 60.28% | 62.12% | 63.92% |
| Biogen Inc. (BIIB)vs › | $33.63B | 67.71% | 73.30% | 74.61% | 77.63% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.08B | 33.15% | 32.39% | 33.17% | 35.04% |
Gross Margin
42.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 41.17% |
| 2026-03-31 | 38.53% |
| 2025-12-31 | 54.30% |
| 2025-09-30 | 38.69% |
| 2025-06-30 | 39.65% |
| 2025-03-31 | 42.12% |
| 2024-12-31 | 42.77% |
| 2024-09-30 | 41.66% |
| 2024-06-30 | 41.37% |
| 2024-03-31 | 40.90% |
| 2023-12-31 | 41.41% |
| 2023-09-30 | 40.13% |
| 2023-06-30 | 40.27% |
| 2023-03-31 | 40.17% |
| 2022-12-31 | 39.13% |
| 2022-09-30 | 38.75% |
| 2022-06-30 | 40.05% |
| 2022-03-31 | 38.64% |
| 2021-12-31 | 40.58% |
| 2021-09-30 | 41.05% |
| 2021-06-30 | 40.80% |
| 2021-03-31 | 40.80% |
